These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 17689366)

  • 21. Normalization and harm reduction: research avenues and policy agendas.
    Erickson PG; Hathaway AD
    Int J Drug Policy; 2010 Mar; 21(2):137-9. PubMed ID: 20022234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ethical, legal and social context of harm reduction.
    Pauly B; Goldstone I; McCall J; Gold F; Payne S
    Can Nurse; 2007 Oct; 103(8):19-23. PubMed ID: 17990401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of peer educator-based harm reduction programmes in Northern Vietnam.
    Walsh N; Gibbie TM; Higgs P
    Drug Alcohol Rev; 2008 Mar; 27(2):200-3. PubMed ID: 18264883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies.
    Rosenberg H; Phillips KT
    Psychol Addict Behav; 2003 Sep; 17(3):203-10. PubMed ID: 14498814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striving for independence: experiences and needs of service users with life limiting conditions.
    Cotterell P
    J Adv Nurs; 2008 Jun; 62(6):665-73. PubMed ID: 18503650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informal payments in government health facilities in Albania: results of a qualitative study.
    Vian T; Gryboski K; Sinoimeri Z; Hall R
    Soc Sci Med; 2006 Feb; 62(4):877-87. PubMed ID: 16115713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harm minimization strategies: opinions of health professionals in rural and remote Australia.
    Peterson GM; Northeast S; Jackson SL; Fitzmaurice KD
    J Clin Pharm Ther; 2007 Oct; 32(5):497-504. PubMed ID: 17875117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serving women who use drugs in Delhi, India: challenges and achievements.
    Sarin E; Selhore E
    Int J Drug Policy; 2008 Apr; 19(2):176-8. PubMed ID: 18313911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoting family-focused approaches within adult drug services: the potential of the 'Senses Framework'.
    Orr LC; Elliott L; Barbour RS
    Int J Drug Policy; 2014 Sep; 25(5):888-96. PubMed ID: 24857625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harm reduction services for British Columbia's First Nation population: a qualitative inquiry into opportunities and barriers for injection drug users.
    Wardman D; Quantz D
    Harm Reduct J; 2006 Oct; 3():30. PubMed ID: 17034636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'They can't solve the problem without us': a qualitative study of stakeholder perspectives on user involvement in drug treatment services in England.
    Patterson S; Weaver T; Agath K; Albert E; Rhodes T; Rutter D; Crawford M
    Health Soc Care Community; 2009 Feb; 17(1):54-62. PubMed ID: 18564192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing health care-seeking behaviours among Mayan women in Guatemala.
    Schooley J; Mundt C; Wagner P; Fullerton J; O'Donnell M
    Midwifery; 2009 Aug; 25(4):411-21. PubMed ID: 18053623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community group practices in Canada: are they ready to reform their practice?
    Murray S; Silver I; Patel D; Dupuis M; Hayes SM; Davis D
    J Contin Educ Health Prof; 2008; 28(2):73-8. PubMed ID: 18521875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards understanding the self-perception of people with a psychotic illness who use illicit substances and have a history of disengagement from mental health services: qualitative research.
    Wagstaff C
    Int J Psychiatr Nurs Res; 2007 May; 12(3):1503-20. PubMed ID: 17682591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is groin injecting an ethical boundary for harm reduction?
    Miller PG; Lintzeris N; Forzisi L
    Int J Drug Policy; 2008 Dec; 19(6):486-91. PubMed ID: 18024001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.